Clinical Document Architecture with Australian Schema, published by Australian Digital Health Agency. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/AuDigitalHealth/cda-au-schema/ and changes regularly. See the Directory of published versions
Draft as of 2024-11-22 |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:ValueSet ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "CDAObservationInterpretation"] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet CDAObservationInterpretation</b></p><a name=\"CDAObservationInterpretation\"> </a><a name=\"hcCDAObservationInterpretation\"> </a><a name=\"CDAObservationInterpretation-en-AU\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html\"><code>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-B\">B</a></td><td style=\"color: #cccccc\">Better</td><td>The current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure).<br/><br/>\\[Note: This can be applied to quantitative or qualitative observations.\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-D\">D</a></td><td style=\"color: #cccccc\">Significant change down</td><td>The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-U\">U</a></td><td style=\"color: #cccccc\">Significant change up</td><td>The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-W\">W</a></td><td style=\"color: #cccccc\">Worse</td><td>The current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure).<br/><br/>\\[Note: This can be applied to quantitative or qualitative observations.\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-.60\"><</a></td><td style=\"color: #cccccc\">Off scale low</td><td>The result is below the minimum detection limit (the test procedure or equipment is the limiting factor).<br/><br/>Synonyms: Below analytical limit, low off scale.</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-.62\">></a></td><td style=\"color: #cccccc\">Off scale high</td><td>The result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor).<br/><br/>Synonyms: Above analytical limit, high off scale.</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-A\">A</a></td><td style=\"color: #cccccc\">Abnormal</td><td>The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure).<br/><br/>\\[Note: Typically applies to non-numeric results.\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-AA\">AA</a></td><td style=\"color: #cccccc\">Critical abnormal</td><td>The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure).<br/><br/>\\[Note: Typically applies to non-numeric results. Analogous to critical/panic limits for numeric results.\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-HH\">HH</a></td><td style=\"color: #cccccc\">Critical high</td><td>The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).<br/><br/>Synonym: Above upper panic limits.</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-LL\">LL</a></td><td style=\"color: #cccccc\">Critical low</td><td>The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).<br/><br/>Synonym: Below lower panic limits.</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-H\">H</a></td><td style=\"color: #cccccc\">High</td><td>The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure).<br/><br/>Synonym: Above high normal</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-L\">L</a></td><td style=\"color: #cccccc\">Low</td><td>The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure).<br/><br/>Synonym: Below low normal</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-N\">N</a></td><td style=\"color: #cccccc\">Normal</td><td>The result or observation value is within the reference range or expected norm (as defined for the respective test procedure).<br/><br/>\\[Note: Applies to numeric or non-numeric results.\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-I\">I</a></td><td style=\"color: #cccccc\">Intermediate</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\\[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\\]<br/><br/>\\[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\\]<br/><br/>\\[Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\\]<br/><br/>\\[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-MS\">MS</a></td><td style=\"color: #cccccc\">moderately susceptible</td><td>The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder.<br/><br/>***Deprecation Comment:*** This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012).</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-R\">R</a></td><td style=\"color: #cccccc\">Resistant</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\\[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.\\]<br/><br/>\\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-S\">S</a></td><td style=\"color: #cccccc\">Susceptible</td><td>Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2<br/><br/>\\[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.\\]<br/><br/>\\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/5.2.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-VS\">VS</a></td><td style=\"color: #cccccc\">very susceptible</td><td>The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder.<br/><br/>***Deprecation Comment:*** This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012).</td></tr></table></li></ul></div>"
] ; #
fhir:url [ fhir:v "http://hl7.org/cda/stds/core/ValueSet/CDAObservationInterpretation"^^xsd:anyURI] ; #
fhir:version [ fhir:v "1.0.0"] ; #
fhir:name [ fhir:v "CDAObservationInterpretation"] ; #
fhir:title [ fhir:v "CDAObservationInterpretation"] ; #
fhir:status [ fhir:v "draft"] ; #
fhir:experimental [ fhir:v "false"^^xsd:boolean] ; #
fhir:date [ fhir:v "2024-11-22T03:02:41+00:00"^^xsd:dateTime] ; #
fhir:description [ fhir:v "One or more codes providing a rough qualitative interpretation of the observation - limited to values available in original CDA"] ; #
fhir:compose [
( fhir:include [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"^^xsd:anyURI ] ;
( fhir:concept [
fhir:code [ fhir:v "B" ] ] [
fhir:code [ fhir:v "D" ] ] [
fhir:code [ fhir:v "U" ] ] [
fhir:code [ fhir:v "W" ] ] [
fhir:code [ fhir:v "<" ] ] [
fhir:code [ fhir:v ">" ] ] [
fhir:code [ fhir:v "A" ] ] [
fhir:code [ fhir:v "AA" ] ] [
fhir:code [ fhir:v "HH" ] ] [
fhir:code [ fhir:v "LL" ] ] [
fhir:code [ fhir:v "H" ] ] [
fhir:code [ fhir:v "L" ] ] [
fhir:code [ fhir:v "N" ] ] [
fhir:code [ fhir:v "I" ] ] [
fhir:code [ fhir:v "MS" ] ] [
fhir:code [ fhir:v "R" ] ] [
fhir:code [ fhir:v "S" ] ] [
fhir:code [ fhir:v "VS" ] ] ) ] )
] . #
IG © 2024+ Australian Digital Health Agency. Package au.digitalhealth.cda.schema#1.0.0 based on FHIR 5.0.0. Generated 2024-11-22
Links: Table of Contents | QA Report | Version History | Report an issue or propose a change
Publisher: Australian Digital Health Agency | ABN: 84 425 496 912, Level 25, 175 Liverpool Street, Sydney, NSW 2000 | Phone: 1300 901 001 | Email: help@digitalhealth.gov.au | https://www.digitalhealth.gov.au | Privacy policy | Terms of Use